Generate a tailored SOP for Dr. Eelko Hak. Improve your application with a focused, well-structured draft.
Professor Eelko Hak specializes in Pharmacoepidemiology at the University of Groningen, where he leads a multidisciplinary team that has supervised over 30 PhD theses. His research focuses on the assessment of (side-) effects of drugs and vaccines utilizing Real-World Big Health Care Biobank Data. Hak employs various scientific methods, including case-control and cohort designs, to explore the effectiveness of preventive medications and vaccination strategies. His extensive work has led to over 400 peer-reviewed publications and a Web of Science H-index of 44. He has served as the program director for the Groningen Research Master in Medical Pharmaceutical Sciences from 2015 to 2020 and has implemented innovations in the pharmaceutical industry, focusing on sustainable drug applications. Hak is committed to mentoring students and establishing rigorous evaluation criteria for research projects, which has significantly improved the quality of education in the pharmacy program he oversees. His leadership also extends to several committees, including the Dutch Health Council, where he contributed to the evaluation of drug trials and vaccination strategies during the COVID-19 pandemic. Through his involvement in various initiatives, he aims to optimize drug use and enhance public health.
University of Groningen • Groningen
Leading research in Clinical Pharmacoepidemiology, overseeing various initiatives and educational programs.
Standard Master's entry requirements for Economics, Business, Finance, Accounting, and Management departments within the Faculty of Economics and Business.